Regional News

Don't miss our other news sources!

Peak 10 Acquires bayMountain to Expand into the Richmond Market
Raleigh-based Peak 10 Inc. (www.peak10.com) acquired bayMountain, of Richmond, Va., to enhance its technical capabilities and service offerings as a data center operator and managed services provider.  Peak 10 is the largest independent company of its type in the eastern United States.  The acquisition will help the company expand to the Northern Virginia, Charlottesville and Tidewater regional markets.  Executives of Peak 10 believe the purchase of bayMountain will further development in security, disaster recovery and business continuity areas. 

[Top of page]

Hatteras Announces Initial Closing of Fund Focused on Early-Stage Companies
Durham-based Hatteras Venture Partners (www.hatterasvp.com) announced today the first closing of its third venture capital fund, Hatteras Venture Partners III, LP (HVP III). The Fund has secured commitments for $60 million to invest in seed and early-stage companies in biopharmaceuticals, medical devices, diagnostics and related opportunities in human medicine. The ultimate fund size is expected to be $100 million.

[Top of page]

Aurora Funds Invests in Point of Sale Information Provider Recordant
The Durham-based Aurora Funds (www.aurorafunds.com) was among the new investors, who provided Recordant, a startup that delivers point of sale information, with $9 million in new financing.  Since its launch in 2005, Recordant has raised $13 million to provide qualitative information to clients to improve employee-customer interaction at the point of sale.  The Aurora Funds, focused on information technology companies, was joined by Pequot Ventures, of New York, in the round of funding.

[Top of page]

Inspire Licenses AzaSite for Ocular Infections
Durham-based Inspire Pharmaceuticals, Inc. (www.inspirepharma.com) has signed an exclusive licensing agreement with InSite Vision Incorporated for the U.S. and Canadian commercialization of AzaSite (1.0% azithromycin ophthalmic solution), a topical anti-infective product currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of bacterial conjunctivitis. Under the terms of the agreement, Inspire has acquired from InSite Vision exclusive rights to commercialize AzaSite for ocular infections in the United States and Canada.

[Top of page]

LabCorp and ARCA Discovery Join to Test the First Cardiovascular Genetic Drug
Burlington-based LabCorp (www.labcorp.com) and Denver-based ARCA Discovery have teamed up to develop a commercial genetic test for bucindolol, a genetically targeted heart failure development by ARCA. LabCorp is excited about the partnership with ARCA because physicians will benefit from its scientific expertise with the genetic tests, which will serve individual patient needs.  The financial details of the partnership have yet to be determined.

[Top of page]

Argos Therapeutics Announces Personalized Immunotherapy Clinical Trial for HIV Patients
Durham-based Argos Therapeutics (www.argostherapeutics.com) has initiated a Phase 1/2 clinical trial to test the immunologic activity and safety of its AGS-004 in HIV-infected adults. The target population for the study is patients with durable viral suppression from highly active antiretroviral therapy (HAART). AGS-004 is a personalized RNA-loaded dendritic cell based immunotherapy that is designed to stimulate the patient’s immune system to target and destroy the patient’s own unique viral burden.

[Top of page]

Quintiles Opens New Data Processing Center in Eastern North Carolina
RTP-based  Quintiles Transnational Corp. (www.quintiles.com) , has opened a new data processing facility in Williamston, N.C. Quintiles completed renovations and equipment installation at the new 10,000-square-foot data processing center in mid-January. The company plans to create at least 60 new jobs at the facility over the next three years. The center will be used primarily for data entry.

[Top of page]

Events Update

12/2 Entrepreneurs Only Workshop™: Life as a Venture Backed Company

What Members are Saying

"CED is a premiere catalyst for networking and access. CED offers one of the best available common grounds for bringing entrepreneurs of all backgrounds together." - Clay Dunnagan, VP of Business Development, Vital Source Technologies (also a FastTrac Tech instructor)